12/5/19 HOSPW Gr. Rds. Benzodiazepines DePrescribing
Currently, there are approximately 11,500 preventale deaths annually due to benzodiazepine with opioid overdose related deaths.
Patients should not be on benzodiazepines if they are on skeletal muscle relaxants, opioids, or z-drugs.
To enhance clinicians' knowledge of the dangers associated with combined use of benzodiazepines (BZDs) and opioids, benzodiazepine pharmacology and deprescribing recommendations.
Primary care physicians and other interested clinicians
Describe the risks of co-prescribing opioids and benzodiazepines.
Review the pharmacology of benzodiazepines.
Recognize when to taper and strategies in implementation.
Review the management of withdrawal.
Planner: Rachel Grande, PharmD, Addiction Medicine and Recovery service
Speaker: David Nguyen, PharmD
Kaiser Permanente Napa/Solano has determined that the speaker and planner(s) do not have affiliations with any corporate organizations that may constitute a conflict of interest with this presentation. Kaiser Permanente Napa/Solano takes responsibility for the content, quality and scientific integrity of this CME activity. Kaiser Permanente does not endorse any brand-name products.
Kaiser Napa Solano Area is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. The Kaiser Napa Solano Area designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™